During the past decade, New York Organ Donor Network conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "New York Organ Donor Network" #1 collaborator was "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 2 trials as a collaborator and "Johns Hopkins University" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "New York Organ Donor Network" are "Acute Kidney Injury" (1 trials), "Deceased Donor Kidney Transplant" (1 trials), "Delayed Graft Function" (1 trials), "End Stage Renal Disease" (1 trials) and "Graft Failure" (1 trials). Many other conditions were trialed in "New York Organ Donor Network" in a lesser frequency.

Most popular intervention types in "New York Organ Donor Network" are "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Assisted CEaD Condition" (1 trials) and "Autonomous CEaD Condition" (1 trials). Other intervention names were less common.

The vast majority of trials in "New York Organ Donor Network" are 2 trials for "All" genders.

Currently, there are NaN active trials in "New York Organ Donor Network". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in New York Organ Donor Network, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in New York Organ Donor Network, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".